Cancer stem cells: the development of new cancer therapeutics.
about
Circulating cancer stem cells: the importance to selectA simple mathematical model based on the cancer stem cell hypothesis suggests kinetic commonalities in solid tumor growthFenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell SpheroidsSynthetic, non-saccharide, glycosaminoglycan mimetics selectively target colon cancer stem cells.Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.Screening of breast cancer stem cell inhibitors using a protein kinase inhibitor library.Isolation and characterization of side population cells from the human ovarian cancer cell line SK-OV-3The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.The proteomics of cancer stem cells: potential clinical applications for innovative research in oncology.Hedgehog and Resident Vascular Stem Cell Fate.How Signaling Molecules Regulate Tumor Microenvironment: Parallels to Wound Repair.New approaches for pediatric rhabdomyosarcoma drug discovery: targeting combinatorial signaling.Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.Effect of the monoclonal antibody TRC105 in combination with Sunitinib on renal tumor derived endothelial cells.Novel molecular insights and new therapeutic strategies in osteosarcoma
P2860
Q26778924-DD1FF8D7-77EB-4AD5-A3F8-937945896572Q28480928-50F49524-A0B4-4F8D-8900-90FFC081C6FEQ28552301-57899F74-6AA2-42B6-B4DA-CAD98B7BD49BQ34061158-70DFA277-7FAD-4F82-BA75-76FFDE44314EQ35794896-1B09314B-08EB-4487-8BC6-BECCB87CC930Q36021018-EBFABCDF-6043-4E80-9688-01BF41311889Q36306909-0112F67D-45E4-4615-8DE7-5BEAC9E9C8A4Q36334147-FA8796BD-AF3D-40CF-9E42-6798106A368AQ36795940-90F9AB78-FFF2-4D68-B0C0-E7D75611BB04Q37940376-BDC849DC-C371-45E3-8802-CF07E0628819Q38524647-6F1AECD1-8562-45EE-9CDE-BEBC814E9173Q47601253-B4B624C0-FC43-4E9C-89CD-C60A3B500B9BQ50804445-76104A1D-EB98-46DC-9E5B-D72BDC048EC4Q52639286-076AE019-AB7D-4752-AACB-F45F7E9B04DFQ54977476-C418BAB6-C66F-495A-AC2B-A5D12FB9602EQ57814118-8454CF47-A48E-4948-AD86-9793A7E379B4
P2860
Cancer stem cells: the development of new cancer therapeutics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer stem cells: the development of new cancer therapeutics.
@en
Cancer stem cells: the development of new cancer therapeutics.
@nl
type
label
Cancer stem cells: the development of new cancer therapeutics.
@en
Cancer stem cells: the development of new cancer therapeutics.
@nl
prefLabel
Cancer stem cells: the development of new cancer therapeutics.
@en
Cancer stem cells: the development of new cancer therapeutics.
@nl
P2093
P2860
P1476
Cancer stem cells: the development of new cancer therapeutics
@en
P2093
Alessandro Pontoglio
Bruno Giardina
Roberto Scatena
P2860
P304
P356
10.1517/14712598.2011.573780
P407
P577
2011-03-30T00:00:00Z